Tauriga Sciences announced plans to commence development of a pharmaceutical grade version of Tauri-Gum™. The Company’s vision is to develop a pharmaceutical product, based off of the Tauri-Gum™ platform that focuses on the potential anti-nausea properties of Cannabinoids.
While this process is preliminary at this stage, the Company believes that a potentially viable roadmap exists, to achieve this corporate initiative. The Company will continually update its shareholders, via future press releases, should material progress be realized.